Timberlyne Therapeutics
PrivateLast Round
Series A
Jan 9, 2025
Est. Valuation
$242.6M
Total Funding Raised
$180M
Company Overview
Timberlyne Therapeutics is a biotechnology company that develops and commercializes monoclonal antibody therapies for autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Timberlyne Therapeutics Comparables
Compare Timberlyne Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biogen | 81% | |
| Hangzhou Shangjian Biotechnology Co., Ltd. | 79% | |
| CASI Pharmaceuticals | 78% | |
Timberlyne Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 9, 2025 |
Key People
Founding team and executive leadership
Timberlyne Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Life Sciences | Series A |
| Boyu Capital | Series A |
| Mountainfield Venture Partners | Series A |
| Braidwell | Series A |
| 3H Health Investment | Series A |
| Abingworth | Series A |
| Lilly Asia Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2025
$180M round raised
Timberlyne Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Timberlyne Therapeutics's valuation, stock price, and market status.